山河药辅
(300452)
| 流通市值：25.56亿 | | | 总市值：30.17亿 |
| 流通股本：1.99亿 | | | 总股本：2.34亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 261,391,437.57 | 942,795,401.5 | 696,502,709.9 | 470,839,549.6 |
| 营业收入 | 261,391,437.57 | 942,795,401.5 | 696,502,709.9 | 470,839,549.6 |
| 二、营业总成本 | 210,786,022.15 | 777,028,261.41 | 570,301,274.26 | 380,930,612.37 |
| 营业成本 | 176,999,425.7 | 643,431,346.38 | 474,492,384.08 | 318,666,886.64 |
| 税金及附加 | 2,843,413.41 | 9,850,333.13 | 7,595,970.81 | 5,182,848.33 |
| 销售费用 | 7,847,580.98 | 30,550,967.44 | 21,355,478.13 | 14,235,260.59 |
| 管理费用 | 7,849,230.9 | 37,777,582.82 | 26,092,398.18 | 15,750,869.07 |
| 研发费用 | 10,667,979.83 | 42,274,314.75 | 31,868,425.59 | 22,051,834.84 |
| 财务费用 | 4,578,391.33 | 13,143,716.89 | 8,896,617.47 | 5,042,912.9 |
| 其中:利息费用 | 3,373,630.82 | 13,144,812.27 | 9,771,583.05 | 6,406,295.58 |
| 其中:利息收入 | 793,649.45 | 1,534,865.17 | 962,224.76 | 643,256.5 |
| 三、其他经营收益 | | | | |
| 加:公允价值变动收益 | -3,117,707.86 | 5,918,220.78 | 1,236,270.72 | 2,367,019.33 |
| 加:投资收益 | 4,627,159.28 | 13,350,434.66 | 11,886,128.19 | 6,232,128.16 |
| 资产处置收益 | -162,386.95 | -960,070.63 | -371,211.49 | -296,889.16 |
| 资产减值损失(新) | - | -58,508.45 | - | - |
| 信用减值损失(新) | 16.1 | 160.21 | -9,841.5 | -12,701.9 |
| 其他收益 | 2,467,378.16 | 15,093,099.19 | 11,315,117.29 | 7,297,880.44 |
| 四、营业利润 | 54,419,874.15 | 199,110,475.85 | 150,257,898.85 | 105,496,374.1 |
| 加:营业外收入 | 79,486.13 | 416,421.54 | 301,633.55 | 213,057.87 |
| 减:营业外支出 | 38,454.25 | 841,945.4 | 194,934.45 | 94,613.49 |
| 五、利润总额 | 54,460,906.03 | 198,684,951.99 | 150,364,597.95 | 105,614,818.48 |
| 减:所得税费用 | 6,985,471.06 | 25,510,251.73 | 17,827,427.52 | 12,380,054.93 |
| 六、净利润 | 47,475,434.97 | 173,174,700.26 | 132,537,170.43 | 93,234,763.55 |
| (一)按经营持续性分类 | | | | |
| 持续经营净利润 | 47,475,434.97 | 173,174,700.26 | 132,537,170.43 | 93,234,763.55 |
| (二)按所有权归属分类 | | | | |
| 归属于母公司股东的净利润 | 47,059,919.32 | 176,552,467.48 | 132,563,910.37 | 93,035,152.04 |
| 少数股东损益 | 415,515.65 | -3,377,767.22 | -26,739.94 | 199,611.51 |
| 扣除非经常损益后的净利润 | 45,532,664.34 | 159,131,785.44 | 119,577,509.58 | 84,754,011.33 |
| 七、每股收益 | | | | |
| (一)基本每股收益 | 0.2 | 0.75 | 0.57 | 0.4 |
| (二)稀释每股收益 | 0.19 | 0.73 | 0.55 | 0.38 |
| 九、综合收益总额 | 47,475,434.97 | 173,174,700.26 | 132,537,170.43 | 93,234,763.55 |
| 归属于母公司股东的综合收益总额 | 47,059,919.32 | 176,552,467.48 | 132,563,910.37 | 93,035,152.04 |
| 归属于少数股东的综合收益总额 | 415,515.65 | -3,377,767.22 | -26,739.94 | 199,611.51 |
| 公告日期 | 2026-04-23 | 2026-04-23 | 2025-10-21 | 2025-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |